Little to no patient benefit to using growth factor for chemotherapies with low infection risk, according to study published in Journal of Clinical Oncology

Source :: Plus Company Updates. November 23, 2016
Publication Year :: 2016
Abstract: Indianapolis, Indiana: Anthem, Inc has issued the following news release: The use of white blood cell growth stimulating factor drugs to reduce risk of infection in women with breast cancer [...]

Subjects :: HealthCore Inc.
Cancer prevention -- Usage -- Health aspects
Chemotherapy -- Usage -- Health aspects
Medical research -- Usage -- Health aspects
Infection -- Risk factors -- Usage -- Health aspects
Infection control -- Usage -- Health aspects
Fever -- Risk factors -- Usage -- Health aspects
General interest
News, opinion and commentary

Tools